已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors

医学 核医学 肺癌 肺容积 放射治疗计划 放射治疗 放射科 磁共振成像 内科学
作者
Ho Young Lee,Grace Lee,D. Ferguson,Shu‐Hui Hsu,Yue-Houng Hu,Elizabeth Huynh,Atchar Sudhyadhom,Christopher L. Williams,D.N. Cagney,Kelly Fitzgerald,Benjamin H. Kann,David Kozono,Jonathan E. Leeman,Raymond H. Mak,Zhaohui Han
出处
期刊:Biomedical Physics & Engineering Express [IOP Publishing]
卷期号:10 (4): 045048-045048 被引量:1
标识
DOI:10.1088/2057-1976/ad567d
摘要

Abstract Objective. We aim to: (1) quantify the benefits of lung sparing using non-adaptive magnetic resonance guided stereotactic body radiotherapy (MRgSBRT) with advanced motion management for peripheral lung cancers compared to conventional x-ray guided SBRT (ConvSBRT); (2) establish a practical decision-making guidance metric to assist a clinician in selecting the appropriate treatment modality. Approach. Eleven patients with peripheral lung cancer who underwent breath-hold, gated MRgSBRT on an MR-guided linear accelerator (MR linac) were studied. Four-dimensional computed tomography (4DCT)-based retrospective planning using an internal target volume (ITV) was performed to simulate ConvSBRT, which were evaluated against the original MRgSBRT plans. Metrics analyzed included planning target volume (PTV) coverage, various lung metrics and the generalized equivalent unform dose (gEUD). A dosimetric predictor for achievable lung metrics was derived to assist future patient triage across modalities. Main results. PTV coverage was high (median V100% > 98%) and comparable for both modalities. MRgSBRT had significantly lower lung doses as measured by V20 (median 3.2% versus 4.2%), mean lung dose (median 3.3 Gy versus 3.8 Gy) and gEUD. Breath-hold, gated MRgSBRT resulted in an average reduction of 47% in PTV volume and an average increase of 19% in lung volume. Strong correlation existed between lung metrics and the ratio of PTV to lung volumes (R PTV/Lungs ) for both modalities, indicating that R PTV/Lungs may serve as a good predictor for achievable lung metrics without the need for pre-planning. A threshold value of R PTV/Lungs < 0.035 is suggested to achieve V20 < 10% using ConvSBRT. MRgSBRT should otherwise be considered if the threshold cannot be met. Significance. The benefits of lung sparing using MRgSBRT were quantified for peripheral lung tumors; R PTV/Lungs was found to be an effective predictor for achievable lung metrics across modalities. R PTV/Lungs can assist a clinician in selecting the appropriate modality without the need for labor-intensive pre-planning, which has significant practical benefit for a busy clinic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
JUSTDOIT发布了新的文献求助10
刚刚
1秒前
2秒前
4秒前
科研通AI6.2应助tt采纳,获得30
4秒前
科研通AI6.1应助tt采纳,获得10
5秒前
粉色棉毛裤完成签到,获得积分10
5秒前
妖九笙完成签到 ,获得积分10
5秒前
耍酷乘云发布了新的文献求助10
5秒前
6秒前
7秒前
滴滴答答发布了新的文献求助10
7秒前
方法完成签到,获得积分10
10秒前
10秒前
korchid发布了新的文献求助20
12秒前
科研通AI6.1应助耍酷乘云采纳,获得10
14秒前
kk_1315完成签到,获得积分0
21秒前
22秒前
24秒前
dasd完成签到,获得积分10
25秒前
完美世界应助123采纳,获得10
26秒前
yeahyeahhh发布了新的文献求助10
27秒前
星辰大海应助顺利毕业采纳,获得10
28秒前
陈洋完成签到 ,获得积分10
30秒前
yangshiyu发布了新的文献求助10
30秒前
33秒前
34秒前
哎小伙子完成签到,获得积分10
36秒前
张帅奔完成签到,获得积分10
37秒前
39秒前
Walalilongla发布了新的文献求助10
39秒前
Eason_C完成签到 ,获得积分10
41秒前
42秒前
yangshiyu完成签到 ,获得积分20
43秒前
binwu完成签到,获得积分10
43秒前
鸟窝发布了新的文献求助10
44秒前
iligll完成签到,获得积分10
45秒前
庾磬发布了新的文献求助10
46秒前
47秒前
lhy12345完成签到 ,获得积分10
49秒前
高分求助中
Annie Ernaux: De la perte au corps glorieux 600
Petrology and Plate Tectonics,2025 500
Optical Coating Design with the Essential Macleod 400
A revision of Limenitis helmanni and its related species (Nymphalidae) from Central and South China 400
Moore's Clinically Oriented Anatomy 10th Edition 400
Direct and Iterative Linear System Solvers 400
Cardiopulmonary Bypass and Mechanical Support: Principles and Practice, Fifth Edition 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6775987
求助须知:如何正确求助?哪些是违规求助? 8499685
关于积分的说明 18108878
捐赠科研通 6073038
什么是DOI,文献DOI怎么找? 3016391
邀请新用户注册赠送积分活动 1993408
关于科研通互助平台的介绍 1974591